Randomized phase 2 therapeutic equivalence study of abiraterone acetate fine particle formulation vs. originator abiraterone acetate in patients with metastatic castration-resistant prostate cancer: The STAAR study
Urologic Oncology: Seminars and Original Investigations | Nov 18, 2017
Abiraterone acetate + prednisolone treatment beyond prostate specific antigen and radiographic progression in metastatic castration-resistant prostate cancer patients
Urologic Oncology: Seminars and Original Investigations | Nov 18, 2017
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer
Urologic Oncology: Seminars and Original Investigations | Nov 03, 2017
|Most read this week